Evidence map›Paper›PMID 30186144›Full record

ArticleCase reports in neurology

Toxic Epidermal Necrolysis in a Patient with Autoimmune Limbic Encephalitis with Anti-Glutamate Receptor Antibodies.

Keiko Hatano, Hideyuki Matsumoto, Akihiko Mitsutake, Junko Yoshimura, Aya Nomura, Sumihisa Imakado, Yukitoshi Takahashi, Hideji Hashida

Open access · goldAbstract readCase Reports
In one paragraph

Article in Case reports in neurology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Keiko HatanoDepartment of Neurology, Japanese Red Cross Medical Center, Tokyo, Japan.
Hideyuki MatsumotoDepartment of Neurology, Japanese Red Cross Medical Center, Tokyo, Japan.
Akihiko MitsutakeDepartment of Neurology, Japanese Red Cross Medical Center, Tokyo, Japan.
Junko YoshimuraDepartment of Dermatology, Japanese Red Cross Medical Center, Tokyo, Japan.
Aya NomuraDepartment of Dermatology, Japanese Red Cross Medical Center, Tokyo, Japan.
Sumihisa ImakadoDepartment of Dermatology, Japanese Red Cross Medical Center, Tokyo, Japan.
Yukitoshi TakahashiDepartment of Pediatrics, National Epilepsy Center, Shizuoka Institute of Epilepsy and Neurological Disorders, Shizuoka, Japan.
Hideji HashidaDepartment of Neurology, Japanese Red Cross Medical Center, Tokyo, Japan.
Japanese Red Cross Medical Center · JPNational Epilepsy Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report on a 44-year-old woman who was diagnosed with toxic epidermal necrolysis (TEN) during the recovery phase from autoimmune limbic encephalitis with anti-glutamate receptor antibodies. Both, autoimmune limbic encephalitis and TEN are very rare diseases. The co-existence of the two diseases has not yet been reported. We speculate that the total of 18 drugs needed for the treatment of encephalitis might have increased the risk of TEN. Similar reports would be required to elucidate the pathophysiology of the co-existence.

Indexed as

Anti-glutamate receptor antibodiesAutoimmune limbic encephalitisToxic epidermal necrolysis (TEN)

Identifiers

PMID30186144
PMCPMC6120415
OpenAlexW2886706838

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.